On September 22-24, the VI All Russia GMP Conference with international participation, organized by the Ministry of Industry and Trade of Russia together with...
The research center of the university will be engaged in the development of new drugs for Russia with improved characteristics of safety and bioavailability profiles, increased stability and ease of use. First of all, they will be innovative pharmaceuticals for women's health, reproductive medicine, neurology and immunology.
The BIOCAD and Shanghai Pharmaceuticals Holding joint venture has announced the enrollment of the first Chinese patient in the Phase III international multicenter clinical trial...
The Ministry of Health of the Russian Federation has issued the 12th version of the Temporary guidelines for the prevention, diagnosis and treatment of...
Ritonavir, used for the treatment of HIV infection and viral hepatitis C, received the marketing authorization certificate and became the first drug in the...
«Pharmaceutical industry can and should be financially self-sufficient,» said Peter Bely, Chairman of the Board of Directors of Promomed Group at the «Strategy Implementation...